Results 181 to 190 of about 154,739 (326)

Mild Short‐Term Caloric Restriction Induces Coordinated Changes That Promote Lipid Deposition While Maintaining Thermogenesis Capacity in Interscapular Brown Adipose Tissue of Male Rats

The FASEB Journal, Volume 40, Issue 3, 15 February 2026.
Rats under mild caloric restriction (85% vs. ad libitum) for 2 weeks show metabolic and structural adaptations in iBAT. Caloric restriction increases glycolysis and triglyceride deposition in the tissue, leading to larger lipid droplets. It also reduces mitochondrial iBAT content, while maintaining iBAT thermogenic potential thanks to an increased ...
Giuliana Panico, Vincenzo Migliaccio, Gabriella Pinto, Anna Iliano, Gianluca Fasciolo, Martina Coletta, Paola Venditti, Maria Moreno, Angela Amoresano, Pieter de Lange, Lillà Lionetti, Assunta Lombardi   +11 more
wiley   +1 more source

Metabolic consequences of oncogenic IDH mutations

, 2015
Seth J. Parker, Christian M. Metallo
openalex   +1 more source

Acoustic Sensing as a Tool for Brain Tumor Diagnostics

Advanced Sensor Research, Volume 5, Issue 2, February 2026.
Surface acoustic wave (SAW) sensing is used to distinguish non‐neoplastic brain tissue from primary and metastatic tumors based on their acoustic attenuation signatures. Ex vivo human brain samples reveal clear tissue‐specific mechanical profiles, correlating with stiffness and malignancy.
Melanie E. M. Stamp, Friederike Liesche‐Starnecker, Tina Schaller, Peter Baumgarten, Nadine Lilla, Dorothee Mielke, David Collins   +6 more
wiley   +1 more source

Vascular differences between glioblastoma IDH-wildtype and astrocytoma IDH -mutant grade 4 at imaging and transcriptomic level [PDF]

, 2022
María del Mar Álvarez‐Torres, Adolfo López‐Cerdán, María de la Iglesia-Vayá, Elies Fuster‐García, Francisco García‐García, Juan M. García‐Gómez   +5 more
openalex   +1 more source

IDH-Mutant Gliomas

, 2020
Kensuke, Tateishi,, Tetsuya, Yamamoto,
openaire   +3 more sources

Analysis of Patients With Monocytic and Monocytic‐Like Acute Myeloid Leukemia, Including AML‐M4 and AML‐M5, Treated With Venetoclax Plus Azacitidine

American Journal of Hematology, Volume 101, Issue 3, Page 577-580, March 2026.
Marina Konopleva, Courtney D. DiNardo, Yan Sun, Paul Jung, Sanam Loghavi, Jalaja Potluri, Monique Dail, Brenda Chyla, Daniel A. Pollyea   +8 more
wiley   +1 more source

Large deletions in the DNA primase large subunit PRIM2 are associated with NADP‐malate dehydrogenase activity in a porcine F2 cross

Animal Genetics, Volume 57, Issue 1, February 2026.
Abstract Large porcine F2 crosses are a valuable resource for discovering QTL and genetic variants for relevant traits. Past studies have been largely limited to SNPs and short insertions and deletions. Structural variants (SVs) are becoming a major area of interest in this respect.
Clemens Falker‐Gieske, Iulia Blaj, Ana‐Marija Krizanac, Isabel Kilic, Paula Reich, Jörn Bennewitz, Jens Tetens   +6 more
wiley   +1 more source

De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma

Cancer Cell, 2022
Diana D. Shi, Milan R. Savani, M. Levitt, Adam C. Wang, J. Endress, Cylaina E. Bird, Joseph Buehler, S. Stopka, M. Regan, Yu-Fen Lin, V. Puliyappadamba, Wenhua Gao, J. Khanal, L. Evans, Joyce H. Lee, Lei Guo, Yiqiong Xiao, Min Xu, Bofu Huang, R. Jennings, D. Bonal, Misty S. Martin-Sandoval, Tammie Dang, Lauren C. Gattie, A. Cameron, Sungwoo Lee, J. Asara, H. Kornblum, T. Mak, R. Looper, Quang-De Nguyen, S. Signoretti, S. Gradl, A. Sutter, M. Jeffers, A. Janzer, M. Lehrman, L. Zacharias, Thomas P Mathews, J. Losman, Timothy E. Richardson, D. Cahill, R. Deberardinis, K. Ligon, Lin Xu, P. Ly, N. Agar, K. Abdullah, I. Harris, W. Kaelin, S. McBrayer   +50 more
semanticscholar   +1 more source

Anti-Apoptotic and Anti-Oxidant Proteins in Glioblastomas: Immunohistochemical Expression of Beclin and DJ-1 and Its Correlation with Prognosis. [PDF]

, 2019
Arcidiacono Biagio, Borrelli Giorgio, Cappabianca Paolo, Del Basso De Caro Marialaura, Donato Annalidia, Donato Giuseppe, Guadagno Elia, Malara Natalia, Pignatiello Sara, Presta Ivan, Solari Domenico, Somma Teresa   +11 more
core   +1 more source

Glucose‐6‐phosphate dehydrogenase deficiency is associated with improved survival in patients with acute myeloid leukemia treated with venetoclax and azacitidine

Cancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency impairs cellular redox balance through reduced NADPH production and is the most common enzymatic disorder‐causing anemia. Venetoclax combined with azacitidine (Ven‐Aza) targets leukemic stem cells by disrupting oxidative phosphorylation and inducing mitochondrial stress. This study
Shira Buchrits, Alon Rozental, Noa Korngold, Ofer Algor, Shirly Partouche, Galit Granot, Pia Raanani, Ofir Wolach   +7 more
wiley   +1 more source